Last reviewed: June 9, 2026 Last updated: June 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The study's purpose was safety, not efficacy, and with 2 subjects it can establish only that those 2 specific people tolerated the infusion
The potential for peptides to one day become approved treatments for a host of debilitating injuries and conditions is immense
As we look ahead into 2026, the discussion around optimal delivery methods for compounds like this is more relevant than ever
Cyanocobalamin injections, though less commonly used in the UK than hydroxocobalamin, can similarly raise serum concentrations
Therefore, it needs to be obtained through high-quality dog food and dietary supplements